During the past decade, Pulmonary Associates, PA conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 18 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pulmonary Associates, PA" #1 sponsor was "Actelion" with 8 trials, followed by "Aeris Therapeutics" with 4 trials sponsored, "Gilead Sciences" with 4 trials sponsored, "Cephalon" with 3 trials sponsored and "Jazz Pharmaceuticals" with 3 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pulmonary Associates, PA" #1 collaborator was "Clinartis" with 2 trials as a collaborator, "Altavant Sciences, Inc." with 1 trials as a collaborator, "Canadian Heart Research Centre" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Pulmonary Associates, PA" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Pulmonary Associates, PA" are "Idiopathic Pulmonary Fibrosis" (8 trials), "Chronic Obstructive Pulmonary Disease" (6 trials), "Pulmonary Arterial Hypertension" (6 trials), "Narcolepsy" (5 trials) and "COPD" (4 trials). Many other conditions were trialed in "Pulmonary Associates, PA" in a lesser frequency.

Most popular intervention types in "Pulmonary Associates, PA" are "Drug" (50 trials), "Device" (6 trials), "Other" (4 trials), "Biological" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "placebo" (3 trials), "tasimelteon" (3 trials), "ADX-N05" (2 trials) and "AZLI" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pulmonary Associates, PA" are 61 trials for "All" genders.

Currently, there are NaN active trials in "Pulmonary Associates, PA". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Pulmonary Associates, PA, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Pulmonary Associates, PA, 12 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".